Lung morphology assessment using MRI: A robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients

Magnetic Resonance in Medicine

Volumn 61, Issue 2, 2009, Pages 299-306

  Failo, Riccarda ^a   Wielopolski, Piotr A ^a   Tiddens, Harm A W M ^a   Hop, Wim C J ^a   Mucelli, Roberto Pozzi ^a   Lequin, Maarten H ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

CF; Lung; MRI; Pediatric

Indexed keywords

BIOLOGICAL ORGANS; CALIFORNIUM; DIAGNOSIS; MAGNETIC RESONANCE IMAGING; MORPHOLOGY; PEDIATRICS;

DIAGNOSTIC QUALITY; IMAGING FEATURES; LUNG; LUNG MORPHOLOGY; ROUTINE MONITORING; SIGNAL INTENSITIES; STEADY STATE FREE PRECESSIONS; TWO DIMENSIONAL (2 D);

COMPUTERIZED TOMOGRAPHY;

ADOLESCENT; ARTICLE; ATELECTASIS; BREATH HOLDING; BRONCHIECTASIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE QUALITY; LUNG FIBROSIS; LUNG STRUCTURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; SCHOOL CHILD; STEADY STATE;

EID: 60749128436     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21841     Document Type: Article

References (68)

1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;15;168:918-951.
2. Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002;15;166(Pt 1):1550-1555.
3. Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW; Pulmozyme Early Intervention Trial Study Group. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr 2001;139:813-820.
4. Merkus PJ, Tiddens H, de Jongste JC. Annual lung function changes in young patients with chronic lung disease. Eur Respir J 2002;19:886-891.
5. Corey M, Edwards L, Levison H, Knowles M. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr 1997;131:809-814.
6. Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Makholm LM, Rock MJ, Splaingard ML. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol 2003;36:230-240.
7. Grum CM, Lynch JP. Chest radiographic findings in cystic fibrosis. Semin Respir Infect 1992;7:193-209.
8. Greene KE, Takasugi J, Godwin JD, Richardson ML, Burke W, Aitken ML. Radiographic changes in acute exacerbations of cystic fibrosis in adults: a pilot study. AJR Am J Roentgenol 1994;163:557-562.
9. Brody A. Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained? Pediatrics 1998;101:1071.
10. Brody AS, Tiddens HA, Castile RG, Coxson HO, de Jong PA, Goldin J, Huda W, Long FR, McNitt-Gray M, Rock M, Robinson TE, Sagel SD. CT Scanning in Cystic Fibrosis Special Interest Group. Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med 2005;15;172:1246-1252.
11. Demirkazik FB, Ariyurek OM, Ozcelik U, Gocmen A, Hassanabad HK, Kiper N. High resolution CT in children with cystic fibrosis: correlation with pulmonary functions and radiographic scores. Eur J Radiol 2001; 37:54-59.
12. Santamaria F, Grillo G, Guidi G, Rotondo A, Raia V, de Ritis G, Sarnelli P, Caterino M, Greco L. Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained? Pediatrics 1998;101: 908-913.
13. Brody AS. Scoring systems for CT in cystic fibrosis: who cares? Radiology 2004;231:296-298.
14. Helbich TH, Heinz-Peer G, Eichler I, Wunderbaldinger C, Götz M, Wojnarowski C, Brasch RC, Herold CJ. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology 1999;213:537-544.
15. Helbich TH, Heinz-Peer G, Fleischmann D, Wojnarowski C, Wunderbaldinger P, Huber S, Eichler I, Herold CJ. Evolution of CT findings in patients with cystic fibrosis. AJR Am J Roentgenol 1999;173:81-88.
16. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991;179:783-788.
17. Maffessanti M, Candusso M, Brizzi F, Piovesana F. Cystic fibrosis in children: HRCT findings and distribution of disease. J Thorac Imaging 1996;11:27-38.
18. Stiglbauer R, Schurawitzki H, Eichler I, Vergesslich KA, Gotz M. High resolution CT in children with cystic fibrosis. Acta Radiol 1992;33: 548-553.
19. Tiddens H. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002;34:228-231.
20. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004;145:32-38.
21. Brody A, Campbell J, Millard S, Moss RB, Heald AE. Relationship between FEV1 and high resolution chest CT findings in CF patients with mild lung disease: baseline data from the AAV2 phase II gene transfer study. Pediatr Pulmonol 2003;36:319.
22. de Jong PA, Lindblad A, Rubin L, Hop WC, de Jongste JC, Brink M, Tiddens HA. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006;61:80-85.
23. de Jong PA, Nakano Y, Lequin MH, Mayo JR, Woods R, Paré PD, Tiddens HA. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004; 23:93-97.
24. de Jong PA, Ottink MD, Robben SG, Lequin MH, Hop WC, Hendriks JJ, Pare PD, Tiddens HA. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 2004;231:434-439.
25. Hatabu H, Gaa J, Tadamura E, Edinburgh KJ, Stock KW, Garpestad E, Edelman RR. MR imaging of pulmonary parenchyma with a half-Fourier single-shot turbo spin echo (HASTE) sequence. Eur J Radiol 1999; 29:152-159.
26. Biederer J, Reuter M, Both M, Muhle C, Grimm J, Graessner J, Heller M. Analysis of artifacts and detail resolution of lung MRI with breath-hold T1-weighted gradient-echo and T2-weighted fast spin echo sequences with respiratory triggering. Eur Radiol 2002;12:378-384.
27. Biederer J. Magnetic resonance imaging: technical aspects and recent developments. Med Klin (Munich) 2005;15;100:62-72.
28. Ohno Y, Oshio K, Uematsu H, Nakatsu M, Gefter WB, Hatabu H. Single-shot half-Fourier RARE sequence with ultra-short inter-echo spacing for lung imaging. J Magn Reson Imaging 2004;20:336-339.
29. Kinsella D, Hamilton A, Goddard P, Duncan A, Carswell F. The role of magnetic resonance imaging in cystic fibrosis. Clin Radiol 1991;44:23-26.
30. Carr DH, Oades P, Trotman-Dickenson B, Mohiaddin R, Wells AU, Bush A. Magnetic Resonance scanning in cystic fibrosis: comparison with computed tomography. Clin Radiol 1995;50:84-89.
31. Eichinger M, Puderbach M, Heussel CP, Kauczor HU. MRI in mucovis-cidosis (cystic fibrosis). Radiologe 2006;46:275-281.
32. 2. Puderbach M, Eichinger M, Gahr J, Ley S, Tuengerthal S, Schmäl A, Fink C, Plathow C, Wiebel M, Müller FM, Kauczor HU. Proton MRI appearance of cystic fibrosis: comparison to CT. Eur Radiol 2006;17: 716-724.
33. Hirsch W, Sorge I, Schluter A, Eichler G, Wenkel R. Assessment of pulmonary air trapping and obstruction in expiration: an experimental MRI study. Magn Reson Imaging 2005;23:991-994.
34. de Jong PA, Nakano Y, Lequin MH, Tiddens HA. Dose reduction of computed tomography in children with cystic fibrosis: is it feasible to reduce the number of images per scan? Pediatr Radiol 2006;36:50-53.
35. de Jong PA, Mayo JR, Golmohammadi K. Estimation ofcancer mortality associated with repetitive computed tomography scanning. Am J Resp Crit Care Med 2006;173:199-203.
36. Eichinger M, Puderbach M, Fink C, Gahr J, Ley S, Plathow C, Tuenger-thal S, Zuna I, Muller FM, Kauczor HU. Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis-initial results. Eur Radiol 2006;6:2147-2152.
37. Parra-Robles J, Cross AR, Santyr GE. Theoretical signal-to-noise ratio and spatial resolution dependence on the magnetic field strength for hyperpolarized noble gas magnetic resonance imaging of human lungs. Med Phys 2005;32:221-229.
38. Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, Bandla H, Farrell PM. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 2006;21:14-21.
39. Plathow C, Ley S, Fink C, Puderbach M, Heilmann M, Zuna I, Kauczor HU. Evaluation of chest motion and volumetry during the breathing cycle by dynamic MRI in healthy subjects: comparison with pulmonary function tests. Invest Radiol 2004;39:202-209.
40. Plathow C, Ley S, Zaporozhan J, Schobinger M, Gruenig E, Puderbach M, Eichinger M, Meinzer HP, Zuna I, Kauczor HU. Assessment of reproducibility and stability of different breath-hold maneuvres by dynamic MRI: comparison between healthy adults and patients with pulmonary hypertension. Eur Radiol 2006;16:173-179.
41. Kotani T, Minami S, Takahashi K, Isobe K, Nakata Y, Takaso M, Inoue M, Maruta T, Akazawa T, Ueda T, Moriya H. An analysis of chest wall and diaphragm motions in patients with idiopathic scoliosis using dynamic breathing MRI. Spine 2004;29:298-302.
42. Biederer J, Both M, Graessner J, Liess C, Jakob P, Reuter M, Heller M. Lung morphology: fast MR imaging assessment with a volumetric interpolated breath-hold technique: initial experience with patients. Radiology 2003;226:242-249.
43. Bader TR, Semelka R, Pedro MS, Armao DM, Brown MA, Molina PL. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. J Magn Reson Imaging 2002;15:31-38.
44. Semelka RC, Cem Balci N, Wilber KP, Fischer LL, Brown MA, Gomez-Caminero A, Molina PL. Breath-hold 3D gradient-echo MR imaging of the lung parenchyma: evaluation of reproducibility of image quality in normals and preliminary observations in patients with disease. J Magn Reson Imaging 2000;11:195-200.
45. Plathow C, Fink C, Ley S, Puderbach M, Eichinger M, Zuna I, Schmähl A, Kauczor HU. Measurement oftumor diameter-dependent mobility of lung tumors by dynamic MRI. Radiother Oncol 2004;73:349-354.
46. Plathow C, Fink C, Ley S, Puderbach M, Eichinger M, Schmahl ̈A, Kauczor HU. Measurement of diaphragmatic length during the breathing cycle by dynamic MRI: comparison between healthy adults and patients with an intrathoracic tumor. Eur Radiol 2004;14:1392-1399.
47. Plathow C, Klopp M, Fink C, Sandner A, Hof H, Puderbach M, Herth F, Schmähl A, Kauczor HU. Quantitative analysis of lung and tumour mobility: comparison of two time-resolved MRI sequences. Br J Radiol 2005;78:836-840.
48. Plathow C, Ley S, Fink C, Puderbach M, Hosch W, Schmahl A, Debus J, Kauczor HU. Analysis of intrathoracic tumor mobility during whole breathing cycle by dynamic MRI. Int J Radiat Oncol Biol Phys 2004;15; 59:952-959.
49. Plathow C, Schoebinger M, Fink C, Ley S, Puderbach M, Eichinger M, Bock M, Meinzer HP, Kauczor HU. Evaluation of lung volumetry using dynamic three-dimensional magnetic resonance imaging. Invest Radiol 2005;40:173-179.
50. Plathow C, Zimmermann H, Fink C, Umathum R, Schöbinger M, Huber P, Zuna I, Debus J, Schlegel W, Meinzer HP, Semmler W, Kauczor HU,
51. Bock M. Influence of different breathing maneuvers on internal and external organ motion: use of fiducial markers in dynamic MRI. Int J Radiat Oncol Biol Phys 2005;62:238-245.
52. Tiddens HA, de Jong P. Update on the application of chest computed tomography scanning to cystic fibrosis. Curr Opin Pulm Med 2006;12: 433-439.
53. Brody AS, Sucharew H, Campbell JD, Millard SP, Molina PL, Klein JS, Quan J. Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 2005;1;172:1128-1132.
54. Slattery DM, Waltz D, Denham B, O'Mahony M, Greally P. Broncho-scopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis. Pediatr Pulmonol 2001;31:383-388.
55. Shah PL, Scott Sf, Hodson ME. Lobar atelectasis in cystic fibrosis and treatment with recombinant human DNase I. Respir Med 1994;88:313-315.
56. Stern RC, Boat TF, Orenstein DM, Wood RE, Matthews LW, Doershuk CF. Treatment and prognosis of lobar and segmental atelectasis in cystic fibrosis. Am Rev Respir Dis 1978;118:821-826.
57. Kalender WA, Rienmuller R, Seissler W, Behr J, Welke M, Fichte H. Measurement of pulmonary parenchymal attenuation: use of spirometric gating with quantitative CT. Radiology 1990;175:265-268.
58. Moroni C, Mascalchi M, Camiciottoli G, Bartolucci M, Falaschi F, Battolla L, Orlandi I, Pistolesi M, Villari N. Comparison of spirometricgated and-ungated HRCT in COPD. J Comput Assist Tomogr 2003;27: 375-379.
59. Orlandi I, Moroni C, Camiciottoli G, Bartolucci M, Belli G, Villari N, Mascalchi M. Spirometric-gated computed tomography quantitative evaluation of lung emphysema in chronic obstructive pulmonary disease: a comparison of 3 techniques. J Comput Assist Tomogr 2004; 28:437-442.
60. Robinson TE, Leung AN, Northway WH, Blankenberg FG, Chan FP, Bloch DA, Holmes TH, Moss RB. Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2003;168:588-593.
61. Judge EP, Dodd J, Masterson JB, Gallagher CG. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest 2006;130:1424-1432.
62. Tiddens HA. Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 2006; 7:202-208.
63. Verdun FR, Schnyder P, Gutierrez D, Gudinchet F. Patient dose optimization in pediatric computerized tomography. Rev Med Suisse 2006; 12;2:1752-1757.
64. Grammaticos P, Fountos G. The physician should benefit, not harm the patient. Hell J Nucl Med 2006;9:82-84.
65. Thomas KE, Parnell-Parmley J, Haidar S, Moineddin R, Charkot E, BenDavid G, Krajewski C. Assessment of radiation dose awareness among pediatricians. Pediatr Radiol 2006;36:823-832.
66. Jimenez S, Jimenez J, Crespo M, Santamarta E, Bousono C, Rodriguez J. Computed tomography in children with cystic fibrosis: a new way to reduce radiation dose. Arch Dis Child 2006;91:388-390.
67. Fiel SB, FitzSimmons S, Schidlow DV. Evolving Demographics of Cystic Fibrosis. Am J Respir Crit Care Med 1994;15:349-355.
68. Kauczor HU. Hyperpolarized helium-3 gas magnetic resonance imaging of the lung. Top Magn Reson Imaging 2003;14:223-230.